Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DaeBong LS is a prominent South Korean life science company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and cosmetic raw materials. Founded in 1986, the company operates across the pharmaceutical, cosmeceutical, and functional food sectors, with a core focus on respiratory, cardiovascular, and gastrointestinal health. DaeBong LS is recognized for its expertise in Green Chemistry and "Clean Beauty" ingredients, utilizing natural products and fermentation technologies to create high-value materials. The company also provides clinical evaluation services through its subsidiary, P&K Skin Research Center, and is a key supplier to major global and domestic pharmaceutical and cosmetic firms. Publicly traded on the KOSDAQ, DaeBong LS continues to invest in R&D for novel drug delivery systems and functional bio-materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DaeBong LS.